PMID: 7019248Jul 1, 1981Paper

In vitro effects of a sulfonylurea on insulin action in adipocytes. Potentiation of insulin-stimulated hexose transport

The Journal of Clinical Investigation
B L Maloff, D H Lockwood

Abstract

The mechanism(s) by which the oral sulfonylurea, tolazamide, exerts its extrapancreatic hypoglycemic effects was studied using rat epididymal adipose tissue maintained 20-44 h in the presence or absence of the drug. Insulin binding, hexose transport and glucose metabolism were compared in adipocytes isolated from the cultured tissue. In contrast to earlier reports that suggested that sulfonylureas alter the binding of insulin, neither receptor number nor affinity were changed by tolazamide treatment. The uptake of the glucose analogs 2-deoxyglucose and 3-0-methylglucose in the absence of insulin (i.e., basal) was also unchanged. However, exposure to tolazamide resulted in a potentiation of the stimulatory effects of insulin by approximately 30% at each hormone concentration assayed (0.4-40 ng/ml). This potentiation was dependent on the tolazamide concentration (0.003-0.30 mg/ml), with a maximal effect observed at therapeutic levels. A tolazamide analog hypoglycemic activity in vivo was found not to enhance either basal or insulin-stimulated uptake in vitro. Conversion of 0.1-5.0 mM glucose to CO2 and total lipids in the presence of insulin was also potentiated by tolazamide treatment. The inability of the drug to directly stimu...Continue Reading

References

Nov 9, 1978·Nature·M N Feinglos, H E Lebovitz
Mar 26, 1976·Molecular and Cellular Biochemistry·M P Czech
Dec 11, 1974·Biochemical and Biophysical Research Communications·J N Livingston, D H Lockwood
Nov 24, 1972·Biochimica Et Biophysica Acta·J GliemannS Gammeltoft
Oct 1, 1972·The Journal of Clinical Endocrinology and Metabolism·W C DuckworthA E Kitabchi
Jun 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·P Cuatrecasas
Oct 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·D BaldwinJ M Olefsky
Sep 1, 1980·The Journal of Clinical Investigation·M J Prince, J M Olefsky
May 30, 1980·Biochemical and Biophysical Research Communications·H T HaiglerI Pastan
Feb 1, 1956·The Journal of Clinical Investigation·V P DOLE

❮ Previous
Next ❯

Citations

Jan 1, 1985·European Journal of Clinical Pharmacology·L GroopF Fyhrqvist
Jan 1, 1985·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·B FrorathH W Rüdiger
Aug 30, 1984·Biochemical and Biophysical Research Communications·C K Buffington, A E Kitabchi
Sep 15, 1995·European Journal of Pharmacology·Y InoueT Kaneko
Mar 21, 2000·Diabetes Research and Clinical Practice·C D AgardhP Nilsson-Ehle
May 1, 1988·Baillière's Clinical Endocrinology and Metabolism·J E Gerich
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·K M TordjmanM M Mueckler
Dec 1, 1991·The Proceedings of the Nutrition Society·C J Bailey
Apr 19, 1986·British Medical Journal·M Nattrass
Feb 20, 2010·Archives of Physiology and Biochemistry·Günter MüllerWendelin Frick
Sep 20, 1985·The American Journal of Medicine·J R Gavin
Nov 30, 1983·The American Journal of Medicine·D H Lockwood, J M Amatruda
Jan 1, 1991·Diabetes Research and Clinical Practice·J F Bak, O Pedersen
Jan 17, 1983·The American Journal of Medicine·R A DeFronzoV Koivisto
Jan 17, 1983·The American Journal of Medicine·D H LockwoodM L McCaleb
Oct 1, 1987·Metabolism: Clinical and Experimental·M B Davidson, G Sladen
Aug 20, 1990·The American Journal of Medicine·D C Simonson
Apr 1, 1987·Diabetes/metabolism Reviews·O G Kolterman
Jul 1, 1987·Diabetic Medicine : a Journal of the British Diabetic Association·C B Hollenbeck, G M Reaven
May 1, 1989·Diabetic Medicine : a Journal of the British Diabetic Association·C Y JengG M Reaven
Jul 13, 1988·Diabetes Research and Clinical Practice·S TaketomiK Yokono
Aug 11, 2007·The International Journal on Drug Policy·Dennis M Gorman, J Charles Huber
Apr 19, 1986·British Medical Journal·E Szabadi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.